Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C

NCT00004804 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

57

Enrollment

NIH

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: interferon alfa

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]